The United Nations calls on Governments across the globe to consider decriminalizing psychedelic drug use and the possession of drugs for personal use.

FDA is helping to speed up the process of researching and approving psilocybin, MDMA, and Ketamine for breakthrough treatments in patients with Depression, Anxiety, PTSD, and even addiction.

It all began with a grassroots movement in Colorado and now over 100 Cities across the U.S. are in the process of decriminalizing Psilocybin Mushrooms for therapeutic use.

As people look for a way to naturally heal, decriminalization of All Entheogenic substances has gained traction across America, Canada, and Mexico.

Today is a special day as we bring awareness, inspiration, and education to the world as we breakdown the barriers and stigma surrounding mental health and inspire a new generation to view and treat mental health in a new light. In 1992, an initiative by The World Federation for Mental Health declared October 10th World Mental Health Day!

Ann Arbor’s City Council unanimously passed the resolution after a campaign organized by Decriminalize Nature Ann Arbor, which had support from the board of directors of Decriminalize Nature. The resolution is adapted from the Decriminalize Nature resolution that passed in Oakland in 2019 and follows a trend of decriminalizing psychedelic substances for breakthrough therapy treatments focused on treating mental and emotional health issues.

Patients can now consult with psychotherapist in a safe setting and treat themselves with all natural medicines including Peyote, Ayahuasca, Psilocybin, Kratom, Iboga and MDMA.

The MORE Act would decriminalize cannabis on the federal level, a current back-and-forth obstacle that states have faced since they were given the authority to legalize on a state level.

Patients already have a Right to Try through the FDA’s humanitarian expanded access program, which gives them hope while protecting them from greedy exploitation. Does the federal Right to Try Act Help or Hurt terminally ill patients and take away important safety protections already in place?

In Canada, a new ePetition (e-2534) is gaining traction to decriminalize psychoactive plants, backed by the group Decriminalize Nature Canada.

This November, Oregonians will vote on The Drug Decriminalization and Addiction Treatment Initiative. Measure 110 would reclassify personal and non-commercial drug possession offenses. Possession of a controlled substance in Schedule I-IV, such as heroin, cocaine, and methamphetamines, would be reclassified from a Class A misdemeanor to a Class E violation resulting in a $100 fine or a completed health assessment.